- Home
- XRTX vs NXGL Comparison
XRTX vs NXGL Comparison
Compare XRTX & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRTX | NXGL |
|---|---|---|
| Founded | 2011 | 1997 |
| Country | Canada | United States |
| Employees | 3 | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 4.9M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | XRTX | NXGL |
|---|---|---|
| Price | $2.25 | $0.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 8.1K | ★ 549.6K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,421,000.00 |
| Revenue This Year | N/A | $50.77 |
| Revenue Next Year | N/A | $46.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.46 |
| 52 Week Low | $0.35 | $0.30 |
| 52 Week High | $3.60 | $2.89 |
Technical Indicators
Market Signals| Indicator | XRTX | NXGL |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 43.32 |
| Support Level | $1.99 | $0.32 |
| Resistance Level | $2.29 | $0.61 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 33.33 | 18.25 |
Price Performance
Historical ComparisonAbout XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.